Acular PF Related Published Studies
Well-designed clinical trials related to Acular PF (Ketorolac Tromethamine Ophthalmic)
Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK. [2009.02]
Acular LS before and during LASIK for the control of pain: a randomized, masked contralateral eye trial. [2009.02]
Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial. [2008.09]
Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. [2008.01]
Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial. [2007.11]
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. [2007.07]
Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification. [2007.07]
Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. [2006.09]
Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation. [2006.08]
The effects of topical ketorolac and indomethacin on measles conjunctivitis: randomized controlled trial. [2006.05]
Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study. [2005.08]
Other research related to Acular PF (Ketorolac Tromethamine Ophthalmic)
Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis. [2008.04]
Double-masked study of the effects of nepafenac 0.1% and ketorolac 0.4% on corneal epithelial wound healing and pain after photorefractive keratectomy. [2007.07]
[Eyelid contact allergic eczema caused by topical ketorolac tromethamine 0.5%] [2006.04]
Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK. [2006.02]
An update on the use of ophthalmic ketorolac tromethamine 0.4%. [2006.01]
Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review. [2005.11]
Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. [2005.01.25]
Other possibly related research studies
Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac. [2006.02]
Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK). [2007.11]
|
